Rebecca Snyder
Brody School of Medicine at ECU
Appearances
- DateMay 9, 2023Long-term survival in patients with localized pancreatic adenocarcinoma (PDAC) or ampullary adenocarcinoma (AA) who undergo resection is rare, even in lymph node (LN)-negative disease…
Presenter
Speakers
The University of Texas MD Anderson Cancer CenterThe University of Texas MD Anderson Cancer CenterThe University of Texas MD Anderson Cancer CenterU.T. MD Anderson Cancer CenterUniv. Texas MD Anderson Cancer CenterBrody School of Medicine at ECU - DateMay 9, 2023Pancreatic ductal adenocarcinoma (PDAC) exists in several morphological subtypes differing in prognostic significance. However, to date, a clinico-morphological correlation of these subtypes in the context of neoadjuvant therapy (NAT) has not been performed…
Presenter
Speakers
The University of Texas MD Anderson Cancer CenterThe University of Texas MD Anderson Cancer CenterThe University of Texas MD Anderson Cancer CenterU.T. MD Anderson Cancer CenterUniv. Texas MD Anderson Cancer CenterBrody School of Medicine at ECU - DateMay 8, 2023SOCIETY: SSAT
Moderators
- DateMay 6, 2023LUNCH AND TRAINEE JEOPARDY! 12:00 PM - 1:00 PM LEADERSHIP FORUM, NETWORKING SESSION AND ROUNDTABLES 4:00 PM - 5:30 PM KEYNOTE ADDRESS: FUTURE SCENARIO PLANNING TO PREDICT THE FUTURE OF SURGERY 4:00 PM - 4:30 PM
Presenter
Speakers
The University of Texas MD Anderson Cancer CenterThe University of Texas MD Anderson Cancer CenterThe University of Texas MD Anderson Cancer CenterU.T. MD Anderson Cancer CenterUniv. Texas MD Anderson Cancer CenterBrody School of Medicine at ECU - DateMay 18, 2024Surgical resection of metastases, especially in the liver and lung, is a potentially curative treatment option for certain patients with Stage IV colorectal cancer, requiring multidisciplinary care…
Presenter
Speakers
Brody School of Medicine at ECU - DateMay 19, 2024Early loss of mesoportal venous patency after reconstruction during pancreatectomy is often due to technical factors, whereas delayed loss is often associated with disease recurrence…
Presenter
Speakers
The University of Texas MD Anderson Cancer CenterU.T. MD Anderson Cancer CenterBrody School of Medicine at ECU - DateMay 19, 2024Formerly validated risk-stratified pancreatectomy clinical pathways decreased index hospitalization stay without increasing readmissions, which remain major contributors to the financial burden of pancreatectomy…
Presenter
Speakers
The University of Texas MD Anderson Cancer CenterBrody School of Medicine at ECUU.T. MD Anderson Cancer Center - DateMay 19, 2024BACKGROUND: Risk-stratified pancreatectomy clinical pathways (RSPCP) are associated with reduced length of stay (LOS) and major complications…
Presenter
Speakers
The University of Texas MD Anderson Cancer CenterU.T. MD Anderson Cancer CenterUniv. Texas MD Anderson Cancer CenterBrody School of Medicine at ECUThe University of Texas MD Anderson Cancer Center - DateMay 19, 2024SOCIETY: SSAT In this panel, we will feature trainees and junior faculty from SSAT international partners to share similarities and differences in the surgical training paradigms across the globe…
Moderators
Stony Brook University HospitalBrody School of Medicine at ECUUniversity of São Paulo